CRLBF
Cresco Labs Inc.
OTC Markets OTCQXUSDEQUITY
Healthcare
DELAYED
Strong sell
-65/100
Last price
0.64
▲ 0.01 (1.59%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
0.63
Day high
0.66
Day low
0.63
Volume
106.44K
Market cap
$236.95M
P/E (TTM)
—
52W range
0.59 – 2.30
Trailing performance
Returnvs SPY
1W
-12.33%
-14.3%
1M
-17.95%
-19.1%
3M
-19.09%
-23.6%
6M
-28.97%
-47.2%
YTD
-47.97%
-62.2%
1Y
-53.96%
-70.4%
3Y
-68.47%
-150.7%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
10 more panels on CRLBF open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
8.37M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 17, 26 | Demchenko (Angela) Senior Officer of Issuer |
EXERCISE | 29.46K | $21.50K | Direct |
| Sep 17, 26 | Marburger (Zachary Austen) Senior Officer of Issuer |
EXERCISE | 23.80K | $17.37K | Direct |
| Sep 17, 26 | Bachtell (Charles Ian) Director of Issuer |
EXERCISE | 1.17M | $852.52K | Direct |
| Sep 17, 26 | Butler (Gregory Randolph) Senior Officer of Issuer |
SELL | 5.00K | $3.65K | Direct |
| Sep 17, 26 | Butler (Gregory Randolph) Senior Officer of Issuer |
EXERCISE | 116.04K | $84.71K | Direct |
| Sep 16, 26 | Butler (Gregory Randolph) Senior Officer of Issuer |
SELL | 9.24K | $6.88K | Direct |
| Sep 16, 26 | Marburger (Zachary Austen) Senior Officer of Issuer |
SELL | 10.00K | $7.17K | Direct |
| Sep 16, 26 | Marburger (Zachary Austen) Senior Officer of Issuer |
SELL | 10.00K | $7.17K | Direct |
| Sep 16, 26 | Marburger (Zachary Austen) Senior Officer of Issuer |
SELL | 10.00K | $7.17K | Direct |
| Sep 16, 26 | Marburger (Zachary Austen) Senior Officer of Issuer |
SELL | 10.00K | $7.23K | Direct |
| Sep 16, 26 | Marburger (Zachary Austen) Senior Officer of Issuer |
SELL | 10.00K | $7.30K | Direct |
| Sep 16, 26 | Marburger (Zachary Austen) Senior Officer of Issuer |
SELL | 30.00K | $21.60K | Direct |
| Sep 14, 26 | Butler (Gregory Randolph) Senior Officer of Issuer |
SELL | 5.00K | $3.65K | Direct |
| Sep 14, 26 | Butler (Gregory Randolph) Senior Officer of Issuer |
SELL | 10.00K | $7.45K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
Bachtell (Charles Ian) |
Director of Issuer | 2.49M | Exercise of rights |
Butler (Gregory Randolph) |
Senior Officer of Issuer | 195.07K | Acquisition or disposition in the public market |
Corcoran (Gerald Francis) |
Director of Issuer | 512.84K | Acquisition or disposition in the public market |
Demchenko (Angela) |
Senior Officer of Issuer | 262.25K | Exercise of rights |
Lustig (Marc) |
Director of Issuer | 36.78M | Exercise of rights |
Marburger (Zachary Austen) |
Senior Officer of Issuer | 397.90K | Exercise of rights |
Sampson (Robert Malcom) |
Director of Issuer | 4.02M | Acquisition or disposition in the public market |
Schetz (John Patrick) |
Senior Officer of Issuer | 75.83K | Acquisition or disposition in the public market |
Schuler (Sharon Elizabeth) |
Senior Officer of Issuer | 70.35K | Exercise of rights |
Fundamentals
Market cap$236.95M
Enterprise value$702.10M
Revenue (TTM)$651.13M
Gross profit$325.08M
EBITDA$111.14M
Net income$-100.92M
EPS (TTM)$-0.28
Free cash flow$24.95M
Total cash$32.87M
Total debt$592.02M
Book value / share$0.96
Shares outstanding354.13M
Float345.07M
Short % of float—
Dividend yield0.00%
Beta (5Y)1.81
Valuation & profitability ratios
Trailing P/E—
Forward P/E-16.00
PEG ratio—
Price / sales—
Price / book0.66
EV / revenue1.08
EV / EBITDA6.32
Gross margin49.93%
Operating margin7.71%
Profit margin-15.50%
Return on equity-36.06%
Return on assets3.00%
Debt / equity224.80
Current ratio1.78
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $655.85M | $724.34M | $770.88M | $842.68M | -9.5% |
| Operating revenue | $655.85M | $724.34M | $770.88M | $842.68M | -9.5% |
| Cost of revenue | $331.28M | $359.89M | $408.52M | $435.67M | -7.9% |
| Gross profit | $324.57M | $364.45M | $362.37M | $407.01M | -10.9% |
| Selling, general & admin | $247.45M | $254.84M | $274.63M | $350.65M | -2.9% |
| Total operating expense | $247.62M | $255.17M | $299.49M | $350.08M | -3.0% |
| Operating income | $76.94M | $109.28M | $62.88M | $56.93M | -29.6% |
| Net interest income | -$56.28M | -$54.60M | -$60.82M | -$57.84M | -3.1% |
| Pre-tax income | -$95.42M | -$10.62M | -$146.90M | -$126.91M | -798.9% |
| Tax provision | $44.62M | $49.87M | $32.95M | $88.94M | -10.5% |
| Net income | -$135.41M | -$74.44M | -$175.52M | -$212.05M | -81.9% |
| Net income to common | -$135.41M | -$74.44M | -$175.52M | -$212.05M | -81.9% |
| Basic EPS | -0.38 | -0.17 | -0.53 | -0.71 | -119.0% |
| Diluted EPS | -0.38 | -0.17 | -0.53 | -0.71 | -119.0% |
| EBIT | -$35.39M | $46.91M | -$83.28M | -$68.39M | -175.5% |
| EBITDA | $20.34M | $112.90M | -$13.97M | -$10.66M | -82.0% |
| Basic shares | 355.01M | 348.60M | 339.71M | 298.16M | +1.8% |
| Diluted shares | 355.01M | 348.60M | 339.71M | 298.16M | +1.8% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $57.90M | $137.56M | $103.43M | $119.34M | -57.9% |
| Cash & short-term investments | $57.90M | $137.56M | $103.43M | $119.34M | -57.9% |
| Accounts receivable | $37.89M | $51.56M | $51.07M | $56.49M | -26.5% |
| Inventory | $98.67M | $83.34M | $107.79M | $134.61M | +18.4% |
| Total current assets | $259.27M | $294.26M | $278.09M | $326.05M | -11.9% |
| Property, plant & equipment | $426.91M | $455.50M | $486.19M | $507.99M | -6.3% |
| Goodwill & intangibles | $483.51M | $577.48M | $576.66M | $738.14M | -16.3% |
| Total assets | $1.20B | $1.36B | $1.36B | $1.58B | -11.7% |
| Total current liabilities | $100.18M | $94.34M | $200.24M | $255.87M | +6.2% |
| Current debt | $7.48M | $9.32M | $9.81M | $9.50M | -19.7% |
| Long-term debt | $417.10M | $460.75M | $497.71M | $476.89M | -9.5% |
| Total debt | $584.16M | $639.64M | $682.76M | $670.17M | -8.7% |
| Total liabilities | $944.80M | $967.18M | $930.40M | $996.01M | -2.3% |
| Retained earnings | -$1.50B | -$1.35B | -$1.27B | -$1.08B | -10.9% |
| Shareholder equity | $340.45M | $474.85M | $505.69M | $627.04M | -28.3% |
| Working capital | $159.09M | $199.92M | $77.84M | $70.18M | -20.4% |
| Net tangible assets | -$143.07M | -$102.62M | -$70.97M | -$111.11M | -39.4% |
| Shares issued | 359.53M | 348.60M | 339.71M | 301.23M | +3.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$140.04M | -$60.49M | -$179.85M | -$215.84M | -131.5% |
| Depreciation & amortisation | $55.74M | $65.99M | $69.30M | $57.73M | -15.5% |
| Stock-based compensation | $11.23M | $14.16M | $16.36M | $23.22M | -20.7% |
| Change in working capital | $26.81M | $34.97M | $15.22M | $13.45M | -23.3% |
| Operating cash flow | $72.89M | $132.48M | $58.56M | $18.74M | -45.0% |
| Capital expenditure | -$38.18M | -$23.49M | -$57.88M | -$86.13M | -62.6% |
| Investing cash flow | -$40.70M | -$25.23M | -$44.59M | -$36.58M | -61.3% |
| Share buybacks | $0 | -$200.00K | $0 | — | +100.0% |
| Financing cash flow | -$82.09M | -$71.48M | -$26.91M | -$86.64M | -14.8% |
| Free cash flow | $34.71M | $108.99M | $681.00K | -$67.39M | -68.2% |
| End cash position | $94.33M | $144.25M | $108.52M | $121.51M | -34.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $173.34M | $151.32M | $161.55M | $164.91M | $163.62M | — | +14.5% |
| Operating revenue | $173.34M | $151.32M | $161.55M | $164.91M | $163.62M | — | +14.5% |
| Cost of revenue | $86.39M | $75.88M | $78.23M | $85.55M | $80.37M | — | +13.9% |
| Gross profit | $86.95M | $75.45M | $83.32M | $79.36M | $83.26M | — | +15.2% |
| Selling, general & admin | $73.59M | $64.28M | $65.40M | $59.17M | $57.85M | — | +14.5% |
| Total operating expense | $73.59M | $64.28M | $65.57M | $59.17M | $57.85M | — | +14.5% |
| Operating income | $13.36M | $11.17M | $17.75M | $20.19M | $25.41M | — | +19.6% |
| Net interest income | -$15.11M | -$14.93M | -$14.33M | -$14.57M | -$13.02M | — | -1.2% |
| Pre-tax income | -$3.60M | -$2.79M | -$87.15M | -$10.10M | $2.74M | — | -28.7% |
| Tax provision | -$18.97M | $14.22M | $1.80M | $11.87M | $16.64M | — | -233.4% |
| Net income | $16.80M | -$13.07M | -$87.59M | -$17.05M | -$16.33M | — | +228.5% |
| Net income to common | $16.80M | -$13.07M | -$87.59M | -$17.05M | -$16.33M | — | +228.5% |
| Basic EPS | 0.05 | -0.04 | — | -0.05 | -0.05 | -0.04 | +225.0% |
| Diluted EPS | 0.04 | -0.04 | — | -0.05 | -0.05 | -0.04 | +200.0% |
| EBIT | $11.92M | $12.54M | -$71.52M | $5.17M | $16.64M | — | -5.0% |
| EBITDA | $26.54M | $26.64M | -$59.22M | $19.87M | $30.68M | — | -0.4% |
| Basic shares | 370.81M | 364.23M | — | 355.54M | 354.29M | 350.24M | +1.8% |
| Diluted shares | 472.32M | 364.23M | — | 355.54M | 354.29M | 350.24M | +29.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $32.87M | $32.34M | $57.90M | $45.41M | $146.61M | +1.6% |
| Cash & short-term investments | $32.87M | $32.34M | $57.90M | $45.41M | $146.61M | +1.6% |
| Accounts receivable | $39.88M | $38.15M | $37.89M | $42.67M | $39.49M | +4.6% |
| Inventory | $111.17M | $108.44M | $98.67M | $92.80M | $89.17M | +2.5% |
| Total current assets | $245.65M | $246.67M | $259.27M | $242.64M | $314.61M | -0.4% |
| Property, plant & equipment | $431.67M | $427.17M | $426.91M | $426.94M | $433.73M | +1.1% |
| Goodwill & intangibles | $543.02M | $497.49M | $483.51M | $575.48M | $572.75M | +9.2% |
| Total assets | $1.26B | $1.20B | $1.20B | $1.28B | $1.35B | +5.4% |
| Total current liabilities | $137.70M | $98.17M | $100.18M | $97.37M | $101.32M | +40.3% |
| Current debt | $7.64M | $7.37M | $7.48M | $6.67M | $9.47M | +3.7% |
| Long-term debt | $419.56M | $418.23M | $417.10M | $326.72M | $371.72M | +0.3% |
| Total debt | $592.02M | $586.78M | $584.16M | $580.76M | $630.91M | +0.9% |
| Total liabilities | $999.97M | $954.65M | $944.80M | $940.17M | $986.85M | +4.7% |
| Retained earnings | -$1.50B | -$1.52B | -$1.50B | -$1.41B | -$1.39B | +1.1% |
| Shareholder equity | $358.69M | $336.03M | $340.45M | $428.34M | $444.47M | +6.7% |
| Working capital | $107.95M | $148.50M | $159.09M | $145.27M | $213.28M | -27.3% |
| Net tangible assets | -$184.33M | -$161.46M | -$143.07M | -$147.15M | -$128.28M | -14.2% |
| Shares issued | 371.85M | 370.50M | 359.53M | 357.42M | 355.43M | +0.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | $15.37M | -$17.01M | -$88.95M | -$21.97M | -$13.89M | — | +190.3% |
| Depreciation & amortisation | $14.62M | $14.10M | $12.30M | $14.71M | $14.04M | — | +3.7% |
| Stock-based compensation | $3.77M | $5.25M | $3.65M | $2.31M | $2.55M | — | -28.2% |
| Change in working capital | $7.47M | -$9.28M | $12.54M | -$5.90M | -$6.12M | — | +180.5% |
| Operating cash flow | $15.43M | -$5.63M | $27.43M | $6.16M | $8.83M | — | +373.9% |
| Capital expenditure | -$10.98M | -$9.92M | -$10.29M | -$7.56M | -$13.30M | — | -10.6% |
| Investing cash flow | -$10.44M | -$13.23M | -$13.24M | -$6.12M | -$14.47M | — | +21.1% |
| Share buybacks | — | — | $0 | $0 | $0 | $0 | — |
| Financing cash flow | -$4.44M | -$8.65M | -$1.79M | -$71.10M | -$3.47M | — | +48.7% |
| Free cash flow | $4.45M | -$15.55M | $17.14M | -$1.39M | -$4.46M | — | +128.6% |
| End cash position | $67.36M | $66.82M | $94.33M | $81.96M | $153.01M | — | +0.8% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.03 | 0.06 | +286.7% |
| Mar 2026 | -0.04 | -0.04 | +5.8% |
| Dec 2025 | -0.03 | -0.03 | +10.4% |
| Sep 2025 | -0.04 | 0.01 | +120.4% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -0.03 | 1 | $173.66M | +5.3% |
| Next quarter | -0.03 | 1 | $173.89M | +7.6% |
| Current year | -0.04 | 1 | $672.19M | +2.5% |
| Next year | -0.04 | 1 | $697.47M | +3.8% |
Analyst targets & ownership
Mean target$2.00
High target$2.00
Low target$2.00
Implied upside212.50%
Analyst count1
ConsensusNONE
Strong buy / Buy1 / 5
Hold0
Sell / Strong sell0 / 0
Held by insiders2.25%
Held by institutions3.39%
Institutions holding10
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
0.70
-8.84% from price
SMA 20
0.72
-11.38% from price
SMA 50
0.74
-13.04% from price
SMA 100
0.78
-17.87% from price
SMA 200
0.92
-30.33% from price
EMA 12
0.69
-7.58% from price
EMA 26
0.72
-11.04% from price
EMA 50
0.74
-13.69% from price
RSI (14)
37.2
Neutral
MACD (12,26,9)
-0.03
Hist -0.01
ATR (14)
0.06
8.65% of price
Realised vol 30D
64.0%
Annualised
Bollinger upper
0.82
20, 2σ
Bollinger lower
0.63
20, 2σ
50 / 200 cross
Death
0.74 vs 0.92
Trend bias
Below 200
-30.33%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.40
More volatile than market
Correlation to SPY
0.14
Largely independent
Realised vol 30D
64.0%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-67.1%
Peak to trough
Max drawdown 5Y
-95.5%
Peak to trough
ATR 14
0.06
8.65% of price
Beta (reported)
1.81
5Y monthly, from filing
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 12, 24 | Needham | MAINTAINED | — | Hold |
| Jun 12, 24 | Zuanic & Associates | INITIATED | — | Overweight |
| May 16, 24 | Wedbush | MAINTAINED | Outperform | Outperform |
| May 16, 24 | Needham | MAINTAINED | Hold | Hold |
| Mar 14, 24 | Roth MKM | MAINTAINED | Neutral | Neutral |
| Mar 20, 23 | Wedbush | MAINTAINED | — | Outperform |
| Feb 24, 23 | Cantor Fitzgerald | MAINTAINED | — | Overweight |
| Dec 30, 22 | Cantor Fitzgerald | MAINTAINED | — | Overweight |
| Dec 20, 22 | Cowen & Co. | DOWNGRADE | Outperform | Market Perform |
| Dec 2, 22 | Wedbush | INITIATED | — | Outperform |
| Aug 18, 22 | Piper Sandler | MAINTAINED | — | Overweight |
| Aug 18, 22 | Cantor Fitzgerald | MAINTAINED | — | Overweight |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split—
Split date—
Headlines
Cresco Labs Announces Filing of Management Information Circular for Annual General and Special Meeting
Business Wire · 13d ago
Cresco Labs Appoints Edward Tilly to Board of Directors
Business Wire · 20d ago
Sell Recreational Cannabis as "Medicine"- Federal Class Action Alleges a "Concerted Campaign"
ACCESS Newswire · 35d ago
Cresco Labs Acquires Nine Pennsylvania Dispensaries in Accretive Transaction to Strengthen Market Leadership
Business Wire · 35d ago
Cannabis's MSO's Perfect Storm: Class Actions, RICO & Insurance Denials?
ACCESS Newswire · 44d ago
Cresco Labs Inc (CRLBF) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth and Strategic ...
GuruFocus.com · 61d ago
Cresco Labs Inc. (CRLBF) Q2 Earnings and Revenues Top Estimates
Zacks · 62d ago
Cresco Labs Reports Second Quarter 2026 Financial Results; Delivers $173 Million in Revenue and $40 Million in Adjusted EBITDA
Business Wire · 62d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.